Why does the US import industrial hemp despite having domestic agricultural capacity?

The US imports significant quantities of industrial hemp for fiber, grain, and material applications despite having the agricultural capacity to grow it domestically, because the domestic industrial hemp supply chain has not developed the scale and reliability that large industrial buyers require. As Joseph Hickey explains, the supply chain must begin with corporate anchor buyers — the Teslas, Fords, and aerospace companies that would use the majority of industrial hemp production — committing to domestic sourcing before farmers can justify planting at the volumes required to support those buyers. Without that corporate commitment, farmers face supply chain uncertainty and regulatory confusion that make industrial hemp cultivation economically risky. Regulatory conflation of industrial hemp with cannabinoid hemp compounds this problem: the regulatory debates driven by cannabinoid product concerns create uncertainty that makes industrial hemp cultivation less attractive to both farmers and their potential industrial customers, who hesitate to anchor their supply chains to a commodity facing unclear regulatory treatment.

What is Canada's certified seed model and why do panelists recommend it for US hemp regulation?

Canada's certified seed exemption allows industrial hemp farmers who purchase government-certified seed at or below the 0.3% THC threshold to operate without ongoing THC testing requirements — because the seed selection itself demonstrates industrial intent. As Hickey explains it: 'If you have your receipt where you're buying a certified seed that's 0.3% or below, then they don't even come out and test you.' Panelists recommend this approach because it provides regulatory clarity through a single verifiable decision point — seed purchase — rather than imposing ongoing testing compliance costs on farmers whose cultivation purpose is evident. This separation allows industrial hemp to be governed under straightforward agricultural rules while cannabinoid hemp products receive the more intensive consumer protection oversight they require, eliminating the regulatory interference that currently makes large industrial supply chain commitments to US hemp impractical.

What are the 2018 Farm Bill's unintended consequences for hemp cannabinoid regulation?

The 2018 Farm Bill's legalization of hemp defined it as cannabis containing less than 0.3% delta-9 THC on a dry weight basis, creating federal legal space for hemp cultivation. However, it also inadvertently created a regulatory arbitrage that allowed cannabinoid products — including CBD, delta-8 THC, delta-10 THC, and other hemp-derived compounds — to develop in ways Congress did not anticipate. As Tyler Klimas observes, what lawmakers had in mind 'is not and has not been what is happening.' The result is a patchwork of state responses — some banning hemp-derived intoxicants, others regulating them as marijuana equivalents, and others creating specific hemp cannabinoid frameworks — without a federal baseline defining what products are permitted, how they must be labeled, what potency standards apply, or through what retail channels they may be sold. Klimas argues this absence of a federal floor, not the Farm Bill's structure itself, is the primary regulatory failure requiring correction.

Why are the FDA's hemp restrictions in SNAP and animal feed problematic?

The FDA's restrictions on hemp in food assistance programs and animal feed are cited by the panel as examples of regulatory posture that exceeds any clear scientific basis. On animal feed, the FDA's 2 ppm restriction on hemp meal in chicken feed — as Hickey illustrates — is 'something you can't quantify: 2 ppm is 2 inches in 15.78 miles.' The restriction prevents industrial hemp grain from being used in mainstream feed applications where its nutritional profile would create meaningful value for farmers and food producers, without a proportionate safety rationale. The announcement excluding hemp foods from SNAP programs similarly restricts consumer access to hemp food products in nutrition assistance without a scientific basis that the panel finds convincing. Both restrictions demonstrate how regulatory caution driven by cannabinoid policy debates spills over into industrial hemp applications — suppressing the development of hemp's agricultural value independent of any cannabinoid concern.

What does Jena Murray's 'regulate the plant and the form factors' framework mean in practice?

Murray's proposed regulatory framework reorients hemp policy around what a product is and how it is consumed — rather than which federal statute legalized the plant from which it was derived. Under a plant-and-form-factor approach, a hemp fiber product, a CBD supplement, and a delta-9 THC beverage would each be regulated according to their actual form, potency, and intended use — not according to whether they came from a plant classified as hemp or marijuana under federal law. This approach addresses the core absurdity of the current framework: a 5mg delta-9 THC beverage derived from hemp faces radically different regulatory treatment than a chemically identical beverage derived from marijuana, despite identical consumer safety considerations. In practice, this would require federal agencies to establish product category standards based on consumption format and potency — aligning with the Reason Foundation's potency-based framework proposal discussed in related hemp beverage analyses — creating the consistent compliance environment that allows both industrial hemp supply chains and cannabinoid product businesses to operate with regulatory predictability.

How does Qredible's compliance platform support hemp businesses navigating regulatory fragmentation?

Hemp businesses face the compliance challenge the panel articulates directly: operating across a patchwork of state frameworks without a federal baseline, with regulatory treatment potentially changing as legislatures and agencies update their approaches. Q-Trust's policy-first architecture addresses this precisely — all compliance monitoring parameters are governed by policy configurations rather than code, meaning that when state regulations change for hemp products, scan parameters and compliance requirements update automatically via compliance bulletins without engineering redeployment. For cannabinoid hemp product companies distributing across states with different regulatory treatments, Q-Trust's state-by-state legal status matrix provides per-product jurisdictional eligibility determination — Legal, Restricted, Prohibited, Grey Area, or Cannot Confirm — driven by actual product documentation rather than merchant self-attestation. MyCOA's blockchain-anchored COA management provides the tamper-proof supply chain documentation that both industrial hemp buyers and cannabinoid product regulators increasingly require as evidence of product compliance independent of the regulatory framework in question.

Hemp's Future Between Agricultural Promise and Cannabinoid Controversy

Category: Videos

Author: The Qredible Team

Date: August 11, 2025

Hemp regulations in the United States remain in a state of confusion, creating significant challenges for farmers, businesses, and consumers alike. With no clear federal framework separating industrial hemp from cannabinoid products, stakeholders find themselves in a complex web of conflicting state laws and uncertain federal guidance.

During a recent Qredible Live Broadcast, industry veterans Joseph Hickey Sr., Jena Murray, and Tyler Klimas shared their perspectives on hemp's regulatory challenges and future pathways. This discussion highlighted how the current regulatory environment creates barriers for both industrial hemp cultivation and responsible cannabinoid product development, leaving American farmers caught in the middle.

Industrial Hemp's Unrealized Potential

America's industrial hemp sector continues to face significant hurdles despite strong demand. As Joe Hickey explained, "The United States imports significant quantities of hemp for industrial purposes today... But yet, we're not getting it from our own farms."

This disconnect stems largely from supply chain uncertainties and regulatory confusion. Without clear separation between industrial hemp and cannabinoid-focused cultivation, many potential industrial users hesitate to commit resources.

"When we talk about a supply chain, which is the lifeblood of any industry, the supply chain in hemp right now has to start with the big corporations, the ones that are going to be using the majority of it, the Teslas, the Fords, the aerospace industry," Hickey noted.

The solution may lie in following Canada's model, which treats industrial hemp farming differently from cannabinoid production:

"What Canada has done is if you have your receipt where you're buying a certified seed that's .3 or below, then they don't even come out and test you," Hickey explained. "They don't do it. You're just free to do whatever you want because if you're growing certified seed... you know, we know that they're growing it for fiber or grain."

The Cannabinoid Confusion

On the cannabinoid side, products derived from hemp face their own regulatory challenges. The 2018 Farm Bill created what some now view as unintended consequences, with cannabinoid products developing in ways Congress may not have anticipated.

Tyler Klimas, former chief cannabis regulator for Nevada, observed: "What they had in their mind or what their anticipations were is not and has not been what is happening. And I think Jenna, you brought up the appropriations language. I think the terminology of quantifiable is very significant."

This confusion has led to a patchwork of state regulations and created market uncertainty for CBD and other hemp-derived compounds. As Brian Fitzpatrick noted during the discussion, "Some states are completely villainizing CBD, hemp, and they just want to kill it all together and any form or trace of THC."

FDA's Problematic Role

The Food and Drug Administration's approach to hemp products remains another significant barrier. Current restrictions affect everything from food assistance programs to animal feed, often with questionable scientific basis.

Hickey highlighted this issue with a striking example: "They won't allow two ppm of hemp meal to be fed to chickens. And nobody realizes what 2 ppm stands for. I mean, in the real world, what does 2 ppm mean? Nobody. It's something you can't quantify. But when you say 2 ppm is 2 inches in 15.78 miles, then it gives you how crazy this is."

Recent decisions have further restricted hemp products: "They just passed the other day. They're not going to allow any hemp foods in SNAP programs," Hickey pointed out. "They just announced that. And the only reason they're doing that is because I have no idea what's behind the FDA's refusal."

Finding a Path Forward

The panel agreed that clear federal guidance separating industrial hemp from cannabinoid products would benefit both sectors. This would involve:

Creating distinct regulatory frameworks for industrial hemp versus cannabinoid products
Establishing clear definitions for intoxicating versus non-intoxicating products
Developing appropriate retail channels for different product categories

Klimas suggested: "We've got to create some kind of baseline rules and restrictions, but also authorizations. And we talk, Brian, a lot. We've got to create the floor, right? And we don't even have a floor."

Murray added: "I think ultimately most of the hemp and marijuana guys want to be able to coexist and just kind of work together and figure it out. I think ultimately it's all the same plant, right? So we should regulate the plant and the form factors."

The Economic Stakes

The current regulatory confusion carries significant economic costs. American farmers miss opportunities for diversification, manufacturers lack domestic supply chains for sustainable materials, and consumers face limited access to beneficial products.

"When you look at like just comparing how much corn is grown in the US to how much hemp is grown, I mean it's like not even 1% if you were to compare to the corn production and 14% of corn production goes overseas today," Fitzpatrick observed.

Building a Sustainable Hemp Future

For hemp to reach its full potential across both industrial and wellness applications, stakeholders must work together to advocate for sensible federal frameworks that acknowledge the plant's diverse uses while addressing legitimate safety concerns.

As the discussion concluded, the consensus was clear: without federal clarity defining separate lanes for industrial hemp and cannabinoid products, both sectors will continue to face unnecessary obstacles. By establishing clear guidelines, testing protocols, and market boundaries, regulators could unleash hemp's economic and environmental benefits while ensuring consumer safety and product integrity.

The path forward requires cooperation between industrial hemp advocates, cannabinoid product manufacturers, and cannabis industry stakeholders to develop common-sense solutions that serve farmers, businesses, and consumers alike.